Abstract
The goal of the study was to examine the Apolipoprotein E (APOE) genotypes in a Tunisian sample of patients with Alzheimer disease (AD) and normal controls, and to compare the results with the findings from the literature. A hospital-based case–control study of two groups (58 patients with AD, 71 controls) was conducted. Patients received a detailed clinical history, neurological examination, neuropsychological testing and brain imaging. A neurological examination and the Arabic version of the Mini-Mental State Examination were made for controls. Genotyping was performed using the PCR restriction fragment length polymorphism (PCR–RFLP) method. There were no statistical differences in age (p = 0.05) and gender (p = 0.046) between the two groups. The APOE ε4/4 genotype was over represented in the AD group in comparison with the controls (13.3 vs. 2.8%). A significant increased risk of AD among APOE ε4 allele carriers was observed. The odds ratio for the association of AD patients with homozygous and heterozygous ε4 allele was, respectively, 5.40 (1.35–21.48) and 2.90 (1.27–6.62). Our results in addition to previously published genetic studies suggest that AD disease is multifactor in origin. Ethnicity, genetic and environmental factors contribute to AD risk in different ethnic groups.
Similar content being viewed by others
References
National Institute on Aging/Alzheimer’s Association Working Group (1996) Apolipoprotein E genotyping in Alzheimer’s disease. Lancet 347:1091–1095
Breitner JC, Wyse BW, Anthony JC (1999) ApoE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County study. Neurology 53:321–331
Terwilliger JD, Ott J (1994) Linkage disequilibrium between alleles at marker loci. In: Handbook of human genetic linkage, The John Hopkins University Press, Baltimore, pp 188–198
Zhong N, Weisgraber KH (2009) Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure. J Biol Chem 284:6027–6031
Farrer LA, Friedland RP, Bowirrat A, Waraska K, Korczyn A, Baldwin C (2003) Genetic and environmental epidemiology of Alzheimer’s disease in Arabs residing in Israel. J Mol Neurosci 20:207–212
Chien-Hsiun C, Toshiki M, Elston R, Kariuki M, Hall K, Unverzagt F et al (2010) A comparative study to screen dementia and APOE genotypes in an ageing East African population. Neurobiol Aging 31:732–740
Kalaria RN, Ogeng’o JA, Patel NB, Sayi JG, Kitinya JN, Chande HM et al (1997) Evaluation of risk factors for Alzheimer’s disease in elderly east Africans. Brain Res Bull 44:573–577
Sayi JG, Patel NB, Premkumar DR, Adem A, Winblad B, Matuja WB et al (1997) Apolipoprotein E polymorphism in elderly east Africans. East Afr Med J 74:668–670
Bellaj T, Ben Jemaa S, Attia Romdhane N, Dhiffallah M, Bouaziz M, Mrabet A (2008) Mini mental state examination Arabic version (A-MMSE): reliability, validity and normative data. La Tunisie Medicale 86:768–776
Ben Jemaa S, Bellaj T, Attia Romdhane N, Oudiaa Zakraoui N, Cherif A et al (2008) Arabic version of the Alzheimer’s disease assessment scale cognitive subscale (A-ADAS COG). La Tunisie Medicale 86:777–785
Ben Jemaa S, Bellaj T, Attia Romdhane N, Cherif A, Oudiaa Zakraoui N, Bouaziz M et al (2008) Frontal assessment battery: reliability, validity and standardization of an Arabic form. La Tunisie Medicale 86:793–800
Bellaj T, Ben Jemaa S, Anane N, Attia Romdhane N, Ben Youssef K, Kahouaji H et al (2008) Geriatric depression scale Arabic version: reliability, validity and normative data. La Tunisie Medicale 86:801–808
Ben Hamouda I, Attia Romdhane N, Ben Youssef K, Mhenni C, Mrabet A (2008) Interrater reliability of the clinical dementia rating scale in Tunisia. La Tunisie Medicale 86:764–767
Attia Romdhane N, Ben Hamouda I, Ben Youssef K, Mhenni C, Ouenniche S, Mrabet A (2008) Reliability and validity of instrumental activities in daily living scale in Tunisia. La Tunisie Medicale 86:764–767
American Psychiatric Association (APA) (1993) Diagnostic and statistical manual of mental disorders. DSM-IV, 4th edn. American Psychiatric Association, Washington, DC
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinial diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34:939–944
Bienvenu T, Meunier C, Bousquet S, Chiron S, Richard L, Gauther-Dejean A, Rouselle J-F, Feldmann D (1999) Les techniques d’extraction de l’ADN à partir d’un échantillon sanguin. Ann Biol Clin 57:77–84
Miller SA, Dykes D, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:12–15
Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548
Hajjem S, Achour N (2001) Espérance de vie sans incapacité de la population tunisienne âgée. Institut National de la Santé Publique, Tunis, pp 17–25
Hajem S, Mrabet A (2008) Epidémiologie des démences en Tunisie. La Tunisie Medicale 86:744–745
Malle E, Pfeiffer KP, Dugi K, Pfeiffer C, Glaum M, Oezcueruemez M et al (1996) Polymorphisms of apolipoprotein A-IV and E in a Turkish population living in Germany. Hum Genet 98:285–290
Chartier-Harlin MC, Parfitt M, Legrain S, Pérez-Tur J, Brousseau T, Evans A et al (1994) Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer’s disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 4:569–574
Betard C, Robitaille Y, Gee M, Tiberghien D, Larrivée D, Roy P et al (1994) Apo E allele frequencies in Alzheimer’s disease, Lewy body dementia, Alzheimer’s disease with cerebrovascular disease and vascular dementia. Neuroreport 15:1893–1896
Raygani A, RahimiZ KharaziH, Tavilani H, Pourmotabbed T (2006) Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer’s disease. Neurosci Lett 408:68–72
Cariobu MA, Kokkofitou A, Manoli P, Christou S, Karagrigoriou A, Middleton L (1995) Under expression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprus. Genet Epidemiol 12:489–497
Norihiro T, Akinori M, Tamao T, Hiroyuki A, Takashi A, The Japanese Genetic Study Consortium for Alzheimer disease et al (2009) Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese. Genomics 93:441–448
Valveny N, Esteban E, Kandi M, Moral P (1997) APOE Polymorphism in Spanish and Moroccan populations. Clin Genet 51:354–356
Bosco P, Gueant-Rodrıguez R, Anello G, Spada R, Romano A, Caraci F et al (2005) Allele ε4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy. Neurosci Lett 388:168–172
Piscopo P, Manfredi A, Malvezzi-Campeggi L, Crestini A, Spadoni O, Cherchi R et al (2006) Genetic study of Sardinian patients with Alzheimer’s disease. Neurosci Lett 398:124–128
Poli M, Benerini Gatta L, Lovati C, Mariani C, Galimberti D, Scarpini E et al (2008) Interaction between the APOE 4 allele and the APH-1b c+651T>G SNP in Alzheimer’s disease. Neurobiol Aging 29:1494–1501
Gureje O, Ogunniyi A, Baiyewu O, Price B, Unverzagt FW et al (2006) APOE epsilon4 is not associated with Alzheimer’s disease in elderly Nigerians. Ann Neurol 59:182–185
Heckmann JM, Low WC, De Villiers C, Rutherfoord S, Vorster A, Rao H et al (2004) Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer’s disease. Brain 127:133–142
Osuntokun BO, Sahota A, Ogunniyi AO, Gureje O, Baiyewu O, Adeyinka A et al (1995) Lack of an association between apolipoprotein E epsilon 4 and Alzheimer’s disease in elderly Nigerians. Ann Neurol 38:463–465
Maestre G, Ottman R, Stern Y, Mayeux R (1995) Apolipoprotein E and Alzheimer’s disease: ethnic variation in genotype risks. Ann Neurol 37:254–259
Hendrie HC, Hall KS, Hui S (1995) Apolipoprotein E genotypes and Alzheimer’s disease in a community study of elderly African Americans. Ann Neurol 37:118–121
Seripa D, Panza F, Franceschi M, D’ Onofrio G, Solfrizzi V, Dallapiccola B, Pilotto A (2009) Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer’s disease. Ageing Res Rev 8:214–236
Lambert JC, Pasquier F, Cottel D, Frigard B, Amouyel P, Chritier-harlin MC (1998) A new polymorphism in the ApoE promoter associated with risk of developing Alzheimer disease. Hum Med Genet 3:533–540
Kim KW, Jhoo JH, Lee KU, Lee DY, Lee JH, Youn JY, Lee BJ, Han SJ, Woo JI (1999) Association between apolipoprotein E polymorphism and Alzheimer’s disease in Koreans. Neurosci Lett 277:145–148
Mak YT, Chiu H, Woo J, Kay R, Chan YS, Hui E, Sze KH, Lun C, Kwok T, Pang CP (1996) Apolipoprotein E genotype and Alzheimer’s disease in Hong Kong elderly Chinese. Neurology 46:146–149
Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55:964–968
Yadong H (2010) A-β-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer’s disease. Trends Mol Med 16:287–294
Richard F, Amouyel P (2001) Genetic susceptibility factors for Alzheimer’s disease. Eur J Pharmacol 412:1–12
Thomas P, Fenech M (2007) A review of genome mutation and Alzheimer’s disease. Mutagenesis 22:15–33
Lopez OL, Pouse S, Kamboh M, Androer R, Gallego ML, Becker JT et al (1998) Apolipoprotein E polymorphism in Alzheimer’ disease: a comparative study of two search populations from Spain and the USA. Eur Neuol 39:229–233
Carrillo MariaC, Blackwell Andrew, Hampel Harald, Lindborg Johan, Sperling Reisa, Schenk Dale et al (2009) Early risk assessment for Alzheimer’s disease. Alzheimer’s Dementia 5:182–196
Acknowledgments
We would like to express our deep thanks to Professor Raj Kalaria for his valuable assistance and article review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rassas, A.A., Mrabet Khiari, H., Hadj Fredj, S. et al. High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population. Neurol Sci 33, 33–37 (2012). https://doi.org/10.1007/s10072-011-0663-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-011-0663-8